Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lederer

Showing results (331-340 of 419) with videos related to

Pageof 42
Sort By:
The Journal of Allergy and Clinical Immunology|January 25, 2024
Blood eosinophils and fractional exhaled nitric oxide are prognostic and predictive biomarkers in childhood asthmaLeonard B Bacharier, Ian D Pavord, Jorge F Maspero, et al.
Annals of the American Thoracic Society|January 24, 2015
Interleukin-6 and tumor necrosis factor-α are associated with quality of life-related symptoms in pulmonary arterial hypertensionLea Ann Matura, Corey E Ventetuolo, Harold I Palevsky, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 12, 2018
Bidirectional transfer of Anelloviridae lineages between graft and host during lung transplantationArwa A Abbas, Jacque C Young, Erik L Clarke, et al.
Nature|February 7, 2003
Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac deathPeter J Mohler, Jean-Jacques Schott, Anthony O Gramolini, et al.
The Lancet. Respiratory Medicine|October 3, 2019
Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trialLuca Richeldi, Evans R Fernández Pérez, Ulrich Costabel, et al.
The Lancet. Respiratory Medicine|November 24, 2016
Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosisSteven D Nathan, Carlo Albera, Williamson Z Bradford, et al.
Thorax|April 7, 2016
Per cent emphysema is associated with respiratory and lung cancer mortality in the general population: a cohort studyElizabeth C Oelsner, J Jeffrey Carr, Paul L Enright, et al.
Allergy|April 14, 2023
Assessment of dupilumab in children with moderate-to-severe type 2 asthma with or without evidence of allergic asthmaNikolaos G Papadopoulos, Stanley J Szefler, Leonard B Bacharier, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 13, 2023
Dupilumab Improves Lung Function Parameters in Pediatric Type 2 Asthma: VOYAGE StudyLeonard B Bacharier, Theresa W Guilbert, Constance H Katelaris, et al.
Thorax|September 10, 2016
Rheumatoid arthritis-associated autoantibodies and subclinical interstitial lung disease: the Multi-Ethnic Study of AtherosclerosisElana J Bernstein, R Graham Barr, John H M Austin, et al.
Pageof 42

Showing results (331-340 of 419) with videos related to

Sort By:
Pageof 42
The Journal of Allergy and Clinical Immunology|January 25, 2024
Blood eosinophils and fractional exhaled nitric oxide are prognostic and predictive biomarkers in childhood asthmaLeonard B Bacharier, Ian D Pavord, Jorge F Maspero, et al.
Annals of the American Thoracic Society|January 24, 2015
Interleukin-6 and tumor necrosis factor-α are associated with quality of life-related symptoms in pulmonary arterial hypertensionLea Ann Matura, Corey E Ventetuolo, Harold I Palevsky, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 12, 2018
Bidirectional transfer of Anelloviridae lineages between graft and host during lung transplantationArwa A Abbas, Jacque C Young, Erik L Clarke, et al.
Nature|February 7, 2003
Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac deathPeter J Mohler, Jean-Jacques Schott, Anthony O Gramolini, et al.
The Lancet. Respiratory Medicine|October 3, 2019
Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trialLuca Richeldi, Evans R Fernández Pérez, Ulrich Costabel, et al.
The Lancet. Respiratory Medicine|November 24, 2016
Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosisSteven D Nathan, Carlo Albera, Williamson Z Bradford, et al.
Thorax|April 7, 2016
Per cent emphysema is associated with respiratory and lung cancer mortality in the general population: a cohort studyElizabeth C Oelsner, J Jeffrey Carr, Paul L Enright, et al.
Allergy|April 14, 2023
Assessment of dupilumab in children with moderate-to-severe type 2 asthma with or without evidence of allergic asthmaNikolaos G Papadopoulos, Stanley J Szefler, Leonard B Bacharier, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 13, 2023
Dupilumab Improves Lung Function Parameters in Pediatric Type 2 Asthma: VOYAGE StudyLeonard B Bacharier, Theresa W Guilbert, Constance H Katelaris, et al.
Thorax|September 10, 2016
Rheumatoid arthritis-associated autoantibodies and subclinical interstitial lung disease: the Multi-Ethnic Study of AtherosclerosisElana J Bernstein, R Graham Barr, John H M Austin, et al.
Pageof 42